Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Neuroscience >> Neurology process >> Growth and Development >> Neurotrophins
Anti-BDNF antibody
See all BDNF products (22) ...
Rabbit polyclonal to BDNF
ELISA, WB, Functional Studiesmore details
Reacts with
Human
Highly pure (>98%) recombinant BDNF (human Brain-Derived Neurotrophic Factor).
Lyophilised:
Reconstitute with 200µl of sterile water.
Store at +4°C.
PBS, pH 7.4, no preservative, sterile filtered
Concentration information loading...
Immunogen affinity purified
Polyclonal
unknown
unknown
Cardiovascular >> Atherosclerosis >> Thrombosis >> Other
Cardiovascular >> Atherosclerosis >> Diabetes associated
Neuroscience >> Neurology process >> Neurodegenerative disease >> Alzheimer's disease >> Other
Neuroscience >> Neurology process >> Neurodegenerative disease >> Huntington's disease
Neuroscience >> Neurology process >> Growth and Development >> Neurotrophins
Our Abpromise guarantee covers the use of ab9793 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ELISA: Use at an assay dependent dilution. (To detect hBDNF by indirect ELISA (using 100 µl/well antibody solution) a concentration of 0.5 - 2.0 µg/ml of this antibody is required. The detection limit is at least 0.2 - 0.4 ng/well of recombinant hBDNF. )
WB: Use a concentration of 0.1 - 0.2 µg/ml.(The detection limit for recombinant hBDNF is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions)
FuncS: Use at an assay dependent dilution. (To yield one-half maximal inhibition [ND50] of the biological activity of hBDNF (2.0 µg/ml), a concentration of 0.54-0.81 µg/ml of this antibody is required.)
During development, promotes the survival and differentiation of selected neuronal populations of the peripheral and central nervous systems. Participates in axonal growth, pathfinding and in the modulation of dendritic growth and morphology. Major regulator of synaptic transmission and plasticity at adult synapses in many regions of the CNS. The versatility of BDNF is emphasized by its contribution to a range of adaptive neuronal responses including long-term potentiation (LTP), long-term depression (LTD), certain forms of short-term synaptic plasticity, as well as homeostatic regulation of intrinsic neuronal excitability.
Brain. Highly expressed in hippocampus, amygdala, cerebral cortex and cerebellum. Also expressed in heart, lung, skeletal muscle, testis, prostate and placenta.
Defects in BDNF are a cause of congenital central hypoventilation syndrome (CCHS) [MIM:209880]; also known as congenital failure of autonomic control or Ondine curse. CCHS is a rare disorder characterized by abnormal control of respiration in the absence of neuromuscular or lung disease, or an identifiable brain stem lesion. A deficiency in autonomic control of respiration results in inadequate or negligible ventilatory and arousal responses to hypercapnia and hypoxemia. CCHS is frequently complicated with neurocristopathies such as Hirschsprung disease that occurs in about 16% of CCHS cases.
Belongs to the NGF-beta family.
The propeptide is N-glycosylated and glycosulfated.
Converted into mature BDNF by plasmin (PLG).
Secreted.
Target information above from: UniProt accessionP23560
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
ab9793 has not yet been referenced specifically in any publications.
Publishing research using ab9793? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
